Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Forma Therapeutics Holdings, Inc. Announces Appointment of John Bishop as Chief Technology Officer

06/14/2021 | 07:13am EDT

Forma Therapeutics Holdings, Inc. announced the appointment of John Bishop, Ph.D., to the leadership team as chief technology officer, effective June 14, 2021. In this role, Dr. Bishop will lead chemistry, manufacturing and control (CMC)-related functions and quality, encompassing Forma’s early pipeline through commercial product. Dr. Bishop’s background includes extensive expertise with CMC development in oncology and hematology. Prior to joining Forma, Dr. Bishop served as senior vice president of pharmaceutical sciences at Epizyme, Inc., where he was a member of the executive team and held overall responsibility for the CMC and quality assurance (QA) functions.


ę S&P Capital IQ 2021
All news about FORMA THERAPEUTICS HOLDINGS, INC.
09/17FORMA THERAPEUTICS : to Participate in Upcoming Investor Conferences
BU
08/17FORMA THERAPEUTICS : HC Wainwright Adjusts Price Target on Forma Therapeutics Holdings to ..
MT
08/13FORMA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/13FORMA THERAPEUTICS' : Q2 Loss Narrows, Operating Expenses Rise
MT
08/13FORMA THERAPEUTICS HOLDINGS, INC. : Results of Operations and Financial Condition (form 8-..
AQ
08/13FORMA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Business U..
BU
08/13Forma Therapeutics Holdings, Inc. Reports Unaudited Consolidated Earnings Results for t..
CI
08/13NORTH AMERICAN MORNING BRIEFING : Blockbuster -3-
DJ
08/06FORMA THERAPEUTICS : to Report Second Quarter 2021 Financial Results and Provide Business ..
BU
08/02FORMA THERAPEUTICS : Craig-Hallum Starts Forma Therapeutics Holdings at Buy With $58 Price..
MT
More news
Analyst Recommendations on FORMA THERAPEUTICS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7,14 M - -
Net income 2021 -166 M - -
Net cash 2021 484 M - -
P/E ratio 2021 -6,36x
Yield 2021 -
Capitalization 1 050 M 1 050 M -
EV / Sales 2021 79,3x
EV / Sales 2022 462x
Nbr of Employees 139
Free-Float 92,2%
Chart FORMA THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Forma Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORMA THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 22,18 $
Average target price 56,29 $
Spread / Average Target 154%
EPS Revisions
Managers and Directors
Frank D. Lee President, Chief Executive Officer & Director
Todd E. Shegog Chief Financial Officer & Senior Vice President
Peter Wirth Chairman
David N. Cook Chief Scientific Officer & Senior Vice President
Patrick Kelly Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
FORMA THERAPEUTICS HOLDINGS, INC.-36.45%1 050
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353